COMPIS - Congenital myopathy intervention study. An open-label, cross over, randomized, controlled study using salbutamol - COMPIS

Vaestra Goetalandsregionen0 个研究点目标入组 20 人开始时间: 2024年3月21日最近更新: 2024年7月22日

试验速览

阶段: 1 期
状态: 招募中
发起方
入组人数: 20

研究概览入排标准研究者记录与标识符相似试验

研究概览

简要总结

暂无简介。

研究设计

研究类型: Interventional

入排标准

年龄范围: 0 至 64（—）
性别: All

入选标准

•Signed informed consent from legal guardians/patients and patient (where applicable)., Subject must have a confirmed CM diagnosis defined as: Clinical symptoms consistent with CM with pathohistological findings on muscle biopsy and known genetic mutation consistent with CM OR Clinical symptoms consistent with CM with unspecific pathohistological changes but known genetic mutation consistent with CM., Stable MFM32 over at least 6 months (between baseline and screening). An increase or decrease of the score with max two points will be allowed., If on other medications- stabile dose for at least 3 months prior to start., At least 1 point on MFM32 at screening visit., 6 years of age to 30 years of age., Women of fertile age can be on oral contraceptives., Underwent cardiac evaluation with ECG and 2D echocardiography in the last 2 years and has no signs or symptoms of cardiac abnormality.

排除标准

•Subject with clinical symptoms consistent with CM but has no confirmed genetic mutation and only unspecific changes on muscle biopsy that are not confined to just CM but can be seen in other disorders., Subject has arrhythmia as seen on ECG, confirmed by cardiologist., Subject has cardiomyopathy as seen on ultrasound, confirmed by cardiologist., Subject has severe behavioral and/ cognitive problems that preclude participation in the study, in the opinion of the investigator;, Subject is allergic or hypersensitive to study drug or any of its constituents., Subject has previous or ongoing medical condition, medical history, physical findings or laboratory abnormalities that could affect safety, make it unlikely that treatment and follow-up will be correctly completed or impair the assessment of study results, in the opinion of the Investigator;, Subject is currently taking any other investigational drug or has taken any other investigational drug within 3 months prior to the first dose of study medication., Subject is planning on participating in any other study during the duration of this study., Female subjects of fertile age that are or are planning to become pregnant during the study., Female subjects that have given birth up to 1 year prior to baseline visit and/or are nursing up to 1 month prior of baseline visit., Subject has a fracture in the last 6 months before the study start or has acquired a fracture during the study. The fracture needs to be on a body part that can affect our study tests and results, in the opinion of the investigator., Younger than 6 years of age and older than 30 years., Subject receives 94 or more points on MFM32 test at screening visit., Subject doesn’t not speak Swedish and a translator is needed in order to perform the tests included in the study., Subject smokes more than 10 cigarettes a day or has smoked more than 10 cigarettes in the last year., Subject has tracheostomy., Subject receives no points on MFM 32 test at screening., Subject has other concomitant chronic diagnosis that can affect the patients motor function, in the opinion of the investigator., Subject is currently or has been on oral corticosteroids in the last 6 months.

研究者

发起方

Vaestra Goetalandsregionen

相似试验

已完成

4 期

Congenital myopathy intervention study

2024-512027-36-00Vaestra Goetalandsregionen, Vaestra Goetalandsregionen20

已完成

不适用

Changes of Motor Function Tests in Congenital Myopathy Subjects Treated With Oral Salbutamol as Compared to no TreatmentCongenital MyopathyNeuromuscular DiseasesMusculoskeletal DiseasesNemaline MyopathyCentronuclear MyopathyMyosin Storage Myopathy

NCT05099107Vastra Gotaland Region18

招募中

不适用

A Natural History Study of RYR1-Related DisordersRyanodine Receptor 1-Related MyopathyRyanodine Receptor 1 Related Disorders

NCT06287762National Institutes of Health Clinical Center (CC)150

招募中

不适用

NCT01403402Cure CMD4,000

已完成

不适用

Aerobic Training in Patients With Congenital MyopathiesCongenital Myopathy

NCT02020187Rigshospitalet, Denmark16